ClinicalTrials.govpublic full text
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
biliary tract cancer, adenocarcinoma, ampullary, antineoplastic agents, chemotherapy, cholangiocarcinoma, cisplatin, digestive system neoplasms, distal bile duct, extrahepatic, first-line chemotherapy, gallbladder
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 884947
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.